The MIT Press Frankfurt Book Fair 2017 DESIGN

Total Page:16

File Type:pdf, Size:1020Kb

The MIT Press Frankfurt Book Fair 2017 DESIGN The MIT Press Frankfurt Book Fair 2017 DESIGN design | computer-human interaction The Materiality of Interaction Notes on the Materials of Interaction Design Mikael Wiberg Smart watches, smart cars, the Internet of things, 3D printing: all signal a trend toward combining digital and analog materials in design. Interac- tion with these new hybrid forms is increasingly mediated through physi- cal materials, and therefore interaction design is increasingly a material concern. In this book, Mikael Wiberg describes the shift in interaction design toward material interactions. He argues that the “material turn” in human-computer interaction has moved beyond a representation- driven paradigm, and he proposes “material-centered interaction design” as a new approach to interaction design and its materials. He calls for interaction design to abandon its narrow focus on what the computer can do and embrace a broader view of interaction design as a practice of imagining and designing interaction through material manifestations. A material-centered approach to interaction design enables a fundamental design method for working across digital, physical, and even immaterial materials in interaction design projects. Wiberg looks at the history of material configurations in comput- ing and traces the shift from metaphors in the design of graphical user interfaces to materiality in tangible user interfaces. He examines interac- tion through a material lens; suggests a new method and foundation for interaction design that accepts the digital as a design material and A new approach to focuses on interaction itself as the form being designed; considers design interaction design that across substrates; introduces the idea of “interactive compositions”; and moves beyond representation argues that the focus on materiality transcends any distinction between and metaphor to focus on the physical and digital. the material manifestations of interaction. Mikael Wiberg is Professor of Informatics and Associate Dean of the Faculty of Social Sciences at Umeå University, Sweden. March 6 x 9, 200 pp. 32 illus. $35.00S/£27.95 cloth 978-0-262-03751-8 82 SPRING 2018 | MITPRESS.MIT.EDU ARCHITECTURE | URBANISM PROFESSIONAL architecture | urbanism Site Planning International Practice Gary Hack Cities are built site by site. Site planning—the art and science of design- ing settlements on the land—encompasses a range of activities under- taken by architects, planners, urban designers, landscape architects, and engineers. This book offers a comprehensive, up-to-date guide to site planning that is global in scope. It covers planning processes and standards, new technologies, sustainability, and cultural context, address- ing the roles of all participants and stakeholders and offering extensive treatment of practices in rapidly urbanizing countries. Kevin Lynch and Gary Hack wrote the classic text on the subject, and this book takes up where the earlier book left off. It can be used as a textbook and will be an essential reference for practitioners. Site Planning consists of forty self-contained modules, organized into five parts: The Art of Site Planning, which presents site planning as a shared enterprise; Understanding Sites, covering the components of site analysis; Planning Sites, covering the processes involved; Site Infra- structure, from transit to waste systems; and Site Prototypes, including housing, recreation, and mixed use. Each module offers a brief introduc- tion, covers standards or approaches, provides examples, and presents in- novative practices in sidebars. The book is lavishly illustrated with 1350 photographs, diagrams, and examples of practice. A comprehensive, Gary Hack has studied, taught, and practiced site planning for more than forty state-of-the-art guide years in the United States, Canada, and other countries. He is Professor Emeri- to site planning, covering tus of Urban Design at MIT, where he headed the Department of Urban Studies planning processes, new and Planning, Professor Emeritus and former Dean of the School of Design at technologies, and the University of Pennsylvania, and Visiting Professor at Tsinghua and Chongq- sustainability, with ing Universities. extensive treatment of practices in rapidly urbanizing countries. April 8 x 10, 800 pp. 1,317 illus. $80.00X/£66.95 paper 978-0-262-53485-7 $120.00X/£99.95 cloth 978-0-262-03738-9 MITPRESS.MIT.EDU | SPRING 2018 77 ART | MEDIA COGNITIVE SCIENCE art | media cognitive science The Metainterface Efficient Cognition The Art of Platforms, Cities, and Clouds The Evolution of Representational Decision Making Christian Ulrik Andersen and Søren Bro Pold Armin W. Schulz The computer interface is both omnipresent and invisible, at Many organisms (including humans) make decisions by relying once embedded in everyday objects and characterized by hid- on mental representations. Not simply a reaction triggered by den exchanges of informa- perception, representational How the interface has tion between objects. The An argument that decision making employs moved from the office interface has moved from representational decision high-level, non-perceptual into culture, as seen in office into culture, with making is more cognitively mental states with content a series of works of net devices, apps, the cloud, and efficient, allowing an to manage interactions with art, software art and data streams as new cultural organism to adjust the environment. A person electronic literature. platforms. In The Metainter- more easily to changes making a decision based on face, Christian Ulrik Ander- in the environment. mental representations, for sen and Søren Bro Pold examine the relationships between art example, takes a step back and interfaces, tracing the interface’s disruption of everyday from her perceptions at the time to assess the nature of the cultural practices. They present a new interface paradigm of world she lives in. But why would organisms rely on represen- cloud services, smart phones, and data capture, and examine tational decision making, and what evolutionary benefits does how particular art forms—including net art, software art and this reliance provide to the decision maker? In Efficient Cognition, electronic literature—seek to reflect and explore this paradigm. Armin Schulz argues that representational decision making can Andersen and Pold argue that despite attempts to make the be more cognitively efficient than non-representational decision interface disappear into smooth access and smart interaction, making. Specifically, he shows that a key driver in the evolution it gradually resurfaces; there is a metainterface to the dis- of representational decision making is that mental representa- placed interface. Art can help us see this; the interface can be tions can enable an organism to save cognitive resources and an important outlet for aesthetic critique. Andersen and Pold adjust more efficiently to changed environments. describe the “semantic capitalism” of a metainterface industry After laying out the foundations of his argument—clarify- that captures user behavior; the metainterface industry’s dis- ing the central questions, the characterization of representa- ruption of everyday urban life, changing how the city is read, tional decision making, and the relevance of an evidential form inhabited, and organized; the ways that the material displace- of evolutionary psychology—Schulz presents his account of ment of the cloud affects the experience of the interface; and the evolution of representational decision making and critically the potential of designing with an awareness of the language considers some of the existing accounts of the subject. He and grammar of interfaces. then applies his account to three open questions concerning the nature of representational decision making: the extended- Christian Ulrik Andersen teaches and researches software and ness of decision making, and when we should expect cognition computer interfaces in the School of Communication and Culture at to extend into the environment; the specialization of decision Aarhus University. Søren Bro Pold is Associate Professor of Digital making and the use of simple heuristics; and the psychological Aesthetics in the School of Communication and Culture at Aarhus University. sources of altruistic behaviors. June | 7 x 9, 240 pp. | 39 illus. Armin W. Schulz is Associate Professor of Philosophy at the Univer- sity of Kansas. $30.00X/£24.95 cloth 978-0-262-03794-5 March | 6 x 9, 288 pp. | 9 illus. $45.00S/£37.95 cloth 978-0-262-03760-0 78 SPRING 2018 | MITPRESS.MIT.EDU COGNITIVE SCIENCE COMPUTER SCIENCE cognitive science | psychology computer science The Illusion of Conscious Will Data Stream Mining NEW EDITION with Practical Examples in MOA Daniel M. Wegner Albert Bifet, Ricard Gavaldà, Geoffrey Holmes, and Bernhard Pfahringer foreword by Daniel Gilbert introduction by Thalia Wheatley Today many information sources—including sensor networks, financial markets, social networks, and healthcare monitor- Do we consciously cause our actions, or do they happen to us? ing—are so-called data Philosophers, psychologists, neuroscientists, theologians, and A hands-on approach streams, arriving sequentially lawyers have long debated to tasks and techniques A new edition of Wegner’s and at high speed. Analy- the existence of free will in data stream mining classic and controversial sis must take place in real versus determinism. With the and real-time analytics, time, with partial data and work, arguing that publication of The
Recommended publications
  • Integrative Oncology — Strong Science Worthy a Goal As Shrinking the Tumour
    CORRESPONDENCE LINK TO ORIGINAL ARTICLE LINK TO AUTHOR’S REPLY oncology programmes is to ease the suf- fering of patients with cancer, which is as Integrative oncology — strong science worthy a goal as shrinking the tumour. The SIO breast cancer clinical guidelines6 pro- is needed for better patient care vide evidence that there is a large enough body of literature to systematically evaluate Heather Greenlee, Suzanna M. Zick, David Rosenthal, Lorenzo Cohen, what works, what does not work, and where more research is needed; the evidence can Barrie Cassileth and Debu Tripathy then help guide clinical decisions. In the cases where there is an absence of clear We read David Gorski’s Opinion article on patients to control chemotherapy-induced clinical research data providing guidance, integrative oncology (Integrative oncology: nausea and vomiting. More than 30 interven- patients and clinicians need to engage in really the best of both worlds? Nature Rev. tions received a Grade C recommendation shared decision-­making when assessing the Cancer 14, 692–700 (2014))1 with both inter- that suggested weaker evidence of benefit due risk–benefit ratio for each therapy. est and dismay. We firmly agree with Gorski to either conflicting study results or small Heather Greenlee is at the Department of that all forms of medical practice should be sample sizes. Seven therapies are not recom- Epidemiology, Mailman School of Public Health, based on evidence supporting safety and mended due to lack of effect, and one was Columbia University, New York, New York 10032, USA. efficacy. In addition, we concur that the field found to be harmful.
    [Show full text]
  • Orac (Alias David Gorski) December 31, 2014 She’S Baa-Aack
    http://scienceblogs.com/insolence/2014/12/31/oh-no-gmos-are-going-to-make-everyone-autistic/ nearly 500 comments Orac (alias David Gorski) December 31, 2014 She’s baa-aack. Remember Stephanie Seneff? When last Orac discussed her, she had been caught dumpster diving into the VAERS database in order to torture the data to make it confess a “link” between aluminum adjuvants in vaccines and acetaminophen and—you guessed it!—autism. It was a bad paper in a bad journal known as Entropy that I deconstructed in detail around two years ago. As I said at the time, I hadn’t seen a “review” article that long and that badly done since the even more horrible article by Helen Ratajczak entitled Theoretical aspects of autism: Causes–A review (which, not surprisingly, was cited approvingly by Seneff et al). Seneff, it turns out, is an MIT scientist, but she is not a scientist with any expertise in autism, epidemiology, or, for that matter, any relevant scientific discipline that would give her the background knowledge and skill set to take on analyzing the epidemiological literature regarding autism. Indeed, she is in the Computer Science and Artificial Intelligence Laboratory at MIT, and her web page theredescribes her thusly: Stephanie Seneff is a Senior Research Scientist at the MIT Computer Science and Artificial Intelligence Laboratory. She received the B.S. degree in Biophysics in 1968, the M.S. and E.E. degrees in Electrical Engineering in 1980, and the Ph.D degree in Electrical Engineering and Computer Science in 1985, all from MIT.
    [Show full text]
  • Hippocrates Now
    Hippocrates Now 35999.indb 1 11/07/2019 14:48 Bloomsbury Studies in Classical Reception Bloomsbury Studies in Classical Reception presents scholarly monographs offering new and innovative research and debate to students and scholars in the reception of Classical Studies. Each volume will explore the appropriation, reconceptualization and recontextualization of various aspects of the Graeco- Roman world and its culture, looking at the impact of the ancient world on modernity. Research will also cover reception within antiquity, the theory and practice of translation, and reception theory. Also available in the Series: Ancient Magic and the Supernatural in the Modern Visual and Performing Arts, edited by Filippo Carlà & Irene Berti Ancient Greek Myth in World Fiction since 1989, edited by Justine McConnell & Edith Hall Antipodean Antiquities, edited by Marguerite Johnson Classics in Extremis, edited by Edmund Richardson Frankenstein and its Classics, edited by Jesse Weiner, Benjamin Eldon Stevens & Brett M. Rogers Greek and Roman Classics in the British Struggle for Social Reform, edited by Henry Stead & Edith Hall Homer’s Iliad and the Trojan War: Dialogues on Tradition, Jan Haywood & Naoíse Mac Sweeney Imagining Xerxes, Emma Bridges Julius Caesar’s Self-Created Image and Its Dramatic Afterlife, Miryana Dimitrova Once and Future Antiquities in Science Fiction and Fantasy, edited by Brett M. Rogers & Benjamin Eldon Stevens Ovid’s Myth of Pygmalion on Screen, Paula James Reading Poetry, Writing Genre, edited by Silvio Bär & Emily Hauser
    [Show full text]
  • The Rise of Acupuncture in the Opioid Epidemic
    Patients in Pain: The Rise of Acupuncture in the Opioid Epidemic Eana Meng Abstract Many pain patients and patients in recovering from substance use disorders seek alternative methods of care, either because they feel isolated from the biomedical establishment or because current pain management approaches do not fully address their suffering. One particular alternative medicine that has become popular is acupuncture. With a long history in this nation, the practice is currently in its third wave of popularity and growing concurrently with the rise of the opioid epidemic. This paper explores the dynamic between biomedicine and acupuncture by focusing in on the patients’ stories of pain and how physicians and acupuncturists have responded to them. It looks at patient narratives and includes interviews from acupuncture schools to recovery centers. This paper is also historical in nature, by briefly looking at the previous rises of acupuncture in the United States, and delving deeper into the Community Acupuncture movement that began in the 1970s. Then, it looks at biomedicine’s response to these historical events, especially in light of the opioid crisis. Questions around therapeutic efficacy and evidence arise throughout, as the paper navigates through the worlds of biomedicine and alternatives. Ultimately, this paper wants the reader to ask themselves: what counts as medicine, and who gets to decide? Biography Eana Meng is recent graduate of Harvard College, where she majored in History of Science. She studies the history of alternative medicines, with a focus on traditional Chinese medicine. Citing This Work We are committed to sharing our work as widely and effectively as possible while protecting our students’ scholarship.
    [Show full text]
  • Why Anti-Vaccine Claims About NVICP Cases Are Wrong
    Minnesota Journal of Law, Science & Technology Volume 20 Issue 1 Article 11 8-7-2019 Using and Misusing Legal Decisions: Why Anti-Vaccine Claims about NVICP Cases Are Wrong Dorit Rubinstein Reiss UC Hastings College of Law Rachel Heap Follow this and additional works at: https://scholarship.law.umn.edu/mjlst Part of the Administrative Law Commons, Health Law and Policy Commons, and the Other Medicine and Health Sciences Commons Recommended Citation Dorit Rubinstein Reiss & Rachel Heap, Using and Misusing Legal Decisions: Why Anti-Vaccine Claims about NVICP Cases Are Wrong, 20 MINN. J.L. SCI. & TECH. 191 (2018). Available at: https://scholarship.law.umn.edu/mjlst/vol20/iss1/11 The Minnesota Journal of Law, Science & Technology is published by the University of Minnesota Libraries Publishing. Using and Misusing Legal Decisions: Why Anti-Vaccine Claims about NVICP Cases Are Wrong Dorit Rubinstein Reiss*and Rachel Heap† Abstract The question of whether vaccines cause autism spectrum disorder (autism, or ASD) has been extensively studied. Studies from different countries around the world, looking at millions of children in total, examined it and found no link. Despite this powerful evidence, the actions of a small group who fervently believe that vaccines cause autism may lead people to question the data. One tactic used to argue that vaccines cause autism is the use of compensation decisions from the National Vaccine Injury Compensation Program to claim such a link. This article demonstrates that not only does the nature of proof in the program make its decisions ill-suited to challenging the science but also that the cases used do not, in their content, support that conclusion.
    [Show full text]
  • College? No, 'Quackery', Say CAM Critics
    CAM NEWS SPECIAL NEWS FEATURE College? No, ‘quackery’, say CAM critics A short report in the British Medical Journal on the fund-raising activities of the new College of Medicine, which aims to promote integrated health care in the NHS, has been followed by a storm of feedback in the BMJ. * This has included a comment from Dr Edzard Ernst headed “College of Quackery” and the statement “this is not ‘excellence’ but outright quackery which has the potential to kill patients”. Michael Ash, BSc, DO, ND, F DipION, responds to the commentary. lternative and integrative The pressure comes from self-styled rhetoric and scientific racialism. practitioners must feel at times skeptics and vocal opponents of CAM, as Integrative and alternative therapies as though their career choice well as a plethora of EU legislation. Finding (CAM) are most effective for patients who is suddenly less than ideal in a way forward can be daunting, and even have already developed chronic illness, or Athe face of relentless attempts to diminish significant organisations such as the who have risk profiles suggesting they will. their role in assisting and improving the recently formed College of Medicine are Despite efforts in the BMJ to health status of their clients and patients. seeing their mission mired in ego-driven inappropriately compare homeopathy with acute medicine interventions, emergency medicine is not the ground on which CAM’s allegedly unsubstantiated and evidence- deficient therapies predominately operate and deliver most benefit. Mainstream medicine development Mainstream medicine (dominated by drugs and surgery) has in the main continued to evolve by remaining heavily reliant on its early 20th century model and its success in attacking infectious diseases, rather than in the resolution and prevention of chronic, complex diseases.
    [Show full text]
  • Key Legislative Points Pertaining to the Licensing and Regulation of Practitioners of Naturopathic Medicine in North America
    Key legislative points pertaining to the licensing and regulation of practitioners of naturopathic medicine in North America January 2018 Britt Marie Hermes, ND (ret.) [email protected] Let me get straight to the point: Naturopathic education is rich in pseudoscience and fake medicine, and it is devoid of legitimate medical training. Naturopaths are not trained in the rigors of medical science, and this leads to a severe lack of competency and a huge risk of patient harm. NDs seem nice and charismatic, but they do not posses medial competency, especially to prescribe drugs. I organized this letter into sections of eight key points that illustrate why legislatures and physicians should worry that naturopaths want to be licensed to practice a “distinct form of primary health care.”1 (Note: I refer to naturopathic doctors as naturopaths for convenience.) KEY POINT #1: Naturopaths graduating from Bastyr University receive 561 hours in “primary care” training, but which is not real primary care medicine. Naturopathic clinical training takes place in a naturopathic teaching clinic, which is an outpatient clinic that caters to a small subset of typically healthy patients. No clinical training takes place in a hospital setting, like it does for medical providers. Clinical training at naturopathic teaching clinics encompasses the diagnosis and treatment of fake medical conditions, such as adrenal fatigue and systemic yeast overgrowth.2,3 Typical naturopathic treatments include supplement and diet based “detox” programs, energy medicine like homeopathy, hydrotherapy like colon irrigation, botanical medicines, intravenous injections of vitamins, and very little conventional medicine.4,5 In other words, naturopaths are trained to treat the “worried well.” Based on how I, and my colleagues, earned our naturopathic degrees from Bastyr University, I can attest that naturopathic graduates tend to exaggerate or miscalculate their training hours.
    [Show full text]
  • 'Alternative' Medicines 20 August 2014
    Experts denounce clinical trials of unscientific, 'alternative' medicines 20 August 2014 Experts writing in the Cell Press journal Trends in science-based medicine rather than evidence-based Molecular Medicine on August 20th call for an end medicine. Biologically plausible treatments should to clinical trials of "highly implausible treatments" advance to randomized clinical trials only when such as homeopathy and reiki. Over the last two there is sufficient preclinical evidence to justify the decades, such complementary and alternative effort, time, and expense, as well as the use of medicine (CAM) treatments have been embraced human subjects. in medical academia despite budget constraints and the fact that they rest on dubious science, they "Somehow this idea has sprung up that to be a say. 'holistic' doctor you have to embrace pseudoscience like homeopathy, reiki, traditional The writers, David Gorski of Wayne State Chinese medicine, and the like, but that's a false University School of Medicine and Steven Novella dichotomy," Gorski said. "If the medical system is of Yale University, argue that, in these cases, the currently too impersonal and patients are rushed medical establishment is essentially testing through office visits because a doctor has to see whether magic works. Gorski and Novella are both more and more patients to cover his salary and editors for Science-Based Medicine, an expenses, then the answer is to find a way to fix organization and blog dedicated to exploring the those problems, not to embrace quackery. complicated relationship between science and 'Integrating' pseudoscience with science-based medicine. medicine isn't going to make science-based medicine better.
    [Show full text]
  • Breast Cancer Diagnosis Fall 2 0 1 1 Breast Cancer Diagnosis Is a Life- We Can Save the Breast by Performing a a Changing Event and Is Accompanied Lumpectomy
    Make the Right Move A PUBLICATION OFTHE BARBARAANN KARMANOS CANCER INSTITUTE What to do after a breast cancer diagnosis Fall 2 0 1 1 breast cancer diagnosis is a life- we can save the breast by performing a A changing event and is accompanied lumpectomy. Many patients will need both 4 Karmanos by concerns, questions and choices to make. surgery and chemotherapy. Many will Addresses Women often feel overwhelmed and ask, also have radiation therapy. Surgeons, Drug Shortage “What do I do now?” oncologists, radiation oncologists, and other Physicians specialists will collaborate to recommend Plan Ahead “If the cancer hasn’t spread beyond the breast, the best course of treatment. This process is see a breast surgeon,” says David Gorski, part of our multidisciplinary team approach M.D., Ph.D., leader of the Breast Cancer to patient care at Karmanos.” 5Clinical Trials Multidisciplinary Team at the Barbara Save Lives Ann Karmanos Cancer Center. “Whenever While breast cancer can be frightening, Creating Better possible, see a specialist. Karmanos has Dr. Gorski says it’s important to remain calm. Treatments some of the finest surgeons, clinicians and oncologists you’ll find anywhere in the world, “Breast cancer is one of the more treatable as well as cutting-edge clinical trials.” cancers, especially when it’s caught early,” 7 Kid Rock he says. “The patient will almost always Supports Patients always want to know if they’ll need have time to get a second opinion and take Cancer Research surgery or chemotherapy. Dr. Gorski says it orderly steps to make a treatment decision.” depends in part on the nature of the tumor.
    [Show full text]
  • “What We Won't Do Is Pretend That the Work of Lunatic Charlatans Is The
    “What we won't do is pretend that the work of lunatic charlatans is the equivalent of true scientific discourse” The Skeptic -Wikipedia's co-founder Jimmy Wales commenting about alternative medicine, March 23, 2014. Encyclopedia Examples of Wikipedia's Assaults and Bias Against Alternative Medicine The following are examples taken from Wikipedia opinion blog] Gorski said that its findings highlight the entries for various Complementary and Alternative conclusion that acupuncture is "a theatrical placebo Medicine that exemplify gross bias and prejudice by whose real history has been reckoned beyond Skeptic editors who monitor and control these pages. recognition." [Note: Acupuncture is increasingly being taught in conventional American medical schools] Alternative Medicine "describes any practice that aims to achieve the healing effects of medicine, but which Image: Wikipedia co-founder Jimmy lacks biological plausibility and is untested, untested or Wales (right) with celebrity Skeptic proven ineffective.... Frequently used derogatory terms and father of the New Atheism for the alternative are new-age or pseudo, with little movement Richard Dawkins distinction from quackery." [Note: 98 of the 198 citations Naturopathy "is a form of recorded in the Wikipedia entry are from Skeptic alternative medicine that employs an publications and blog sites; 126 of the 140 US medical array of pseudoscientific practices schools require alternative medicine courses] branded as "natural", "non-invasive", Complementary Medicine or Integrative Medicine "is or promoting "self-healing"... when alternative medicine is used together with naturopaths have repeatedly been denounced as and functional medical treatment, in a belief that it improves accused of being charlatans and practicing quackery." the effect of treatments.
    [Show full text]
  • Non-Therapeutic Uses and the Fda
    DRAFT NON-THERAPEUTIC USES AND THE FDA Patricia J. Zettler* Abstract Although debates about the FDA’s gatekeeping role for new drugs and devices often—and understandably—focus on its application to important therapies for patients, the FDA’s premarket review authorities also extend to non-therapeutic uses of drugs and devices. For example, technologies intended to enhance the cognitive or athletic performance of healthy individuals, breast implants used for solely aesthetic reasons, drugs that eliminate frown lines, and recreational drugs used to produce a “high” or some other biological impact might all fall within the agency’s drug and device jurisdiction. This Article explores how the FDA has implemented its premarket review authorities for such non-therapeutic uses of drugs and devices to further understanding of the FDA’s gatekeeping function. It argues that, at least for aesthetic uses, the agency has not treated non- therapeutic uses dramatically differently than therapeutic uses. The agency has authorized non-therapeutic uses even when they are associated with small benefits, serious risks, or both, and will accept various forms of effectiveness evidence for non-therapeutic uses including subjects’ own evaluations of the effects. This approach to authorizing non-therapeutic uses of drugs and devices, at first blush, may seem inconsistent with the FDA’s role as a consumer protection agency charged with protecting and promoting the public health. But this Article demonstrates that numerous different approaches to regulating non-therapeutic uses could be consistent with the consumer protection and information-related purposes of premarket review. * Patricia J. Zettler is an associate professor at Georgia State University College of Law.
    [Show full text]
  • Annual Review 2017/18
    ANNUAL REVIEW Because evidence matters 2017/18 Picture credit: James Hopkirk That is why, in June 2017, over 100 people came with us to the European Parliament, from different walks of life across the EU, to tell MEPs why evidence matters to them. It is why our AllTrials campaign has pressed forward with patient groups to influence the biggest regulators and research funders in the world; why we are encouraging statisticians and others in public life to engage people more in the creation of independent accountable information; and why our Transparency of Evidence review published in January urged the UK government to place greater trust in the public’s ability to handle the fact that policy evidence is rarely complete and definitive. And that is also why it’s so important that researchers put themselves where people For 15 years, Sense about Science need them. Our Voice of Young Science has been at the sharp end of helping network has been equipping researchers to people to grapple with evidence – to take responsibility for the way their field is appreciate it, discuss it and assess discussed in wider society. whether it can bear the weight Looking ahead, European governments have someone wants to put on it. Our spent billions on data strategies, so at Sense work over that time has changed as about Science we will be making sure that the the debates and issues around us public is equipped to ask searching questions have. Our mission – to promote the about quality from the outset. We will be public interest in sound science and working with the UK parliament on the very first evidence – is the same.
    [Show full text]